Profile data is unavailable for this security.
About the company
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is engaged in the development of monoclonal antibodies for treatment of diseases, such as neuromuscular disorders, cancer, fibrosis, and anemia. The Company's lead product candidate is SRK-015 that is in its pre-clinical stage of development. SRK-015 is a selective inhibitor of the activation of the growth factor myostatin in skeletal muscle. It is used to treat spinal muscular atrophy (SMA). The Company also develops other antibody programs that include TGFβ1 and BMP6. The TGFβ1 antibody program is focused on the development of antibodies that are specific inhibitors of TGFβ1 members.
- Revenue in USD (TTM)12.92m
- Net income in USD-54.39m
- Incorporated2017
- Employees69.00
- LocationScholar Rock Holding Corp620 Memorial Dr Fl 2CAMBRIDGE 02139-4815United StatesUSA
- Phone+1 (857) 259-3860
- Fax+1 (302) 655-5049
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiasma Inc | 0.00 | -32.35m | 222.69m | 18.00 | -- | 2.30 | -- | -- | -1.14 | -1.14 | 0.00 | 2.30 | 0.00 | -- | -- | 0.00 | -41.01 | -39.02 | -46.40 | -44.28 | -- | -- | -- | -1,185.77 | -- | -- | 0.0137 | -- | -- | -- | -21.04 | -- | -23.81 | -- |
| Chromadex Corp | 42.27m | -31.51m | 222.82m | 100.00 | -- | 8.18 | -- | 5.27 | -0.5641 | -0.5641 | 0.7557 | 0.4571 | 0.9376 | 2.28 | 9.40 | 422,690.00 | -69.90 | -44.49 | -95.23 | -62.69 | 54.45 | 45.40 | -74.55 | -55.08 | 2.41 | -36.88 | 0.0128 | -- | 48.84 | 25.44 | -101.55 | -- | 45.02 | -- |
| Aeglea Bio Therapeutics Inc | 0.00 | -71.66m | 224.35m | 75.00 | -- | 2.81 | -- | -- | -2.42 | -2.42 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -83.63 | -55.82 | -96.53 | -61.49 | -- | -- | -- | -580.25 | -- | -- | 0.0008 | -- | -25.30 | -- | -62.83 | -- | -- | -- |
| Eloxx Pharmaceuticals Inc | 0.00 | -53.27m | 229.22m | 29.00 | -- | 5.06 | -- | -- | -1.45 | -1.45 | 0.00 | 1.13 | 0.00 | -- | -- | 0.00 | -85.51 | -- | -98.38 | -- | -- | -- | -- | -- | -- | -227.27 | 0.2451 | -- | -- | -- | -99.78 | -- | -- | -- |
| Sutro Biopharma Inc | 50.52m | -42.45m | 230.90m | 169.00 | -- | 2.10 | -- | 4.57 | -1.85 | -1.85 | 2.21 | 4.76 | 0.319 | -- | 10.13 | 343,653.10 | -26.81 | -- | -34.80 | -- | -- | -- | -84.03 | -- | -- | -- | 0.0936 | -- | -25.75 | -- | -79.38 | -- | -- | -- |
| Inovio Pharmaceuticals Inc | 6.34m | -114.66m | 233.02m | 281.00 | -- | 6.85 | -- | 36.78 | -1.18 | -1.18 | 0.0649 | 0.3402 | 0.0434 | -- | 3.51 | 22,544.70 | -78.96 | -39.71 | -95.28 | -49.23 | -- | -- | -1,821.08 | -203.75 | -- | -19.61 | 0.6599 | -- | -27.80 | 17.75 | -9.93 | -- | 63.78 | -- |
| Xeris Pharmaceuticals Inc | 1.69m | -112.92m | 234.32m | 134.00 | -- | 5.36 | -- | 138.49 | -4.54 | -4.54 | 0.0688 | 1.62 | 0.0127 | -- | 1.30 | 18,800.00 | -85.00 | -- | -94.22 | -- | 98.05 | -- | -6,673.58 | -- | -- | -29.72 | 0.5711 | -- | 58.42 | -- | -126.26 | -- | -- | -- |
| Scholar Rock Holding Corp | 12.92m | -54.39m | 237.13m | 69.00 | -- | 1.95 | -- | 18.36 | -2.41 | -2.41 | 0.536 | 4.10 | 0.0868 | -- | -- | 198,753.80 | -36.56 | -- | -41.96 | -- | -- | -- | -421.03 | -- | -- | -- | 0.00 | -- | -- | -- | -97.34 | -- | -- | -- |
| Calithera Biosciences Inc | 0.00 | -87.63m | 237.69m | 79.00 | -- | 1.97 | -- | -- | -2.08 | -2.08 | 0.00 | 2.24 | 0.00 | -- | -- | 0.00 | -59.61 | -33.84 | -66.17 | -38.25 | -- | -- | -- | -362.62 | -- | -- | 0.00 | -- | -14.26 | -- | -96.32 | -- | 5.47 | -- |
| RenovaCare Inc | 0.00 | -2.74m | 238.47m | 1.00 | -- | 18.14 | -- | -- | -0.0322 | -0.0322 | 0.00 | 0.1505 | 0.00 | -- | -- | 0.00 | -35.48 | -82.08 | -37.10 | -91.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.51 | -- | -- | -- |
| Syndax Pharmaceuticals Inc | 1.52m | -60.88m | 239.11m | 38.00 | -- | 5.43 | -- | 157.72 | -2.11 | -2.11 | 0.0518 | 1.62 | 0.0175 | -- | 6.45 | 39,894.74 | -70.45 | -55.88 | -88.53 | -64.01 | -- | -- | -4,016.10 | -4,078.62 | -- | -- | 0.00 | -- | -28.04 | -- | -21.64 | -- | 37.53 | -- |
| Minerva Neurosciences Inc | 0.00 | -55.47m | 239.62m | 13.00 | -- | 4.32 | -- | -- | -1.42 | -1.42 | 0.00 | 1.42 | 0.00 | -- | -- | 0.00 | -42.45 | -37.35 | -44.81 | -39.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -22.60 | -- | -- | -- |
| Hookipa Pharma Inc | -100.00bn | -100.00bn | 241.38m | 60.00 | -- | 1.92 | -- | -- | -- | -- | -- | 4.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0404 | -- | -- | -- | -27.62 | -- | -- | -- |
| ADMA Biologics Inc | 21.37m | -55.76m | 244.98m | 318.00 | -- | 6.78 | -- | 11.46 | -1.12 | -1.12 | 0.4185 | 0.6089 | 0.1751 | 1.44 | 3.74 | 67,196.38 | -45.68 | -67.44 | -50.90 | -79.07 | -82.30 | -35.08 | -260.93 | -257.95 | 3.76 | -7.14 | 0.7001 | -- | -25.37 | 40.82 | -50.24 | -- | 60.52 | -- |
| MannKind Corporation | 63.08m | -47.39m | 245.63m | 225.00 | -- | -- | -- | 3.89 | -0.2575 | -0.2575 | 0.3423 | -0.8949 | 0.8979 | 8.35 | 18.43 | 280,342.20 | -67.46 | -72.07 | -571.60 | -- | 57.15 | -- | -75.13 | -301.11 | 0.903 | -13.39 | -- | -- | 137.20 | -- | 25.87 | -- | -46.38 | -- |
| Kalvista Pharmaceuticals Inc | 14.11m | -25.72m | 251.82m | 45.00 | -- | 2.58 | -- | 17.85 | -1.48 | -1.48 | 0.8092 | 5.48 | 0.1153 | -- | 1.50 | 313,444.40 | -21.03 | -- | -24.13 | -- | -- | -- | -182.37 | -- | -- | -- | 0.00 | -- | 92.13 | -- | -31.71 | -- | -- | -- |
Data as of Dec 06 2019. Currency figures normalised to Scholar Rock Holding Corp's reporting currency: US Dollar USD
53.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co.as of 30 Sep 2019 | 4.44m | 14.95% |
| Redmile Group LLCas of 30 Sep 2019 | 2.86m | 9.63% |
| Invus Public Equities Advisors LLCas of 30 Sep 2019 | 2.35m | 7.90% |
| Bellevue Asset Management AGas of 30 Sep 2019 | 2.20m | 7.40% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2019 | 1.27m | 4.29% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 908.17k | 3.06% |
| BlackRock Fund Advisorsas of 30 Sep 2019 | 829.87k | 2.80% |
| Jefferies Investment Advisers LLCas of 30 Sep 2019 | 408.93k | 1.38% |
| SSgA Funds Management, Inc.as of 30 Sep 2019 | 322.53k | 1.09% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 255.00k | 0.86% |
More ▼
Data from 31 Dec 2018 - 30 Sep 2019Source: FactSet Research Systems Inc.
